The focus of the Capital Markets Day is the US launch of BONESUPPORT’s antibiotic eluting product CERAMENT G, which recently received market authorization from the US FDA.
The focus of the Capital Markets Day is the US launch of BONESUPPORT’s antibiotic eluting product CERAMENT G, which recently received market authorization from the US FDA.